Find clinical trials for Multiple Myeloma in Sevilla, AN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Myeloma trials near Sevilla, AN, ESP:
(DRd) to that of lenalidomide and dexamethasone (Rd), in terms of progression-free survival in participants with relapsed or refractory multiple...
Phase 3
Sevilla, Spain and 145 other locations
Patients included in the study will receive induction treatment during 6 months, followed by receive high-dose therapy followed by peripheral blood s...
Phase 2
Sevilla, Spain and 15 other locations
after Intensification therapy) and safety of Tec-Dara (Teclistamab+Daratumumab) and Tal-Dara (Talquetamab+Daratumumab) in de novo high-risk multiple...
Phase 2
Sevilla, Spain and 9 other locations
versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) followed by Autologous Stem Cell Transplant (ASCT) in newly diagnosed multiple...
Phase 3
Sevilla, Spain and 117 other locations
low-dose dexamethasone (SVd) versus bortezomib plus low-dose dexamethasone (Vd) in adult patients with RRMM who have received 1 to 3 prior anti-multiple...
Phase 3
Seville, Spain and 156 other locations
(Arm A) compared with that of combination of pomalidomide, bortezomib and dexamethasone (Arm B) in participants with relapsed/refractory multiple...
Phase 3
Sevilla, Spain and 129 other locations
compared with VMP alone in participants with previously untreated multiple myeloma who are ineligible for high dose chemotherapy an...
Phase 3
Sevilla, Spain and 164 other locations
Multiple myeloma (MM) is a plasma cell disease characterized by the growth of clonal plasma cells in the bone marrow. The purpose o...
Phase 1
Sevilla, Spain and 48 other locations
dexamethasone) in newly diagnosed (ND) transplant eligible multiple myeloma (MM) patients.Eligible patients will be included in the...
Phase 2
Sevilla, Andalucia, Spain and 17 other locations
A study designed tocompare progression-free survival (PFS) in participants with t(11;14)-positive MM treated with venetoclax in combination with dexa...
Phase 3
Sevilla, Spain and 180 other locations
Clinical trials
Research sites
Resources
Legal